Guardant Health (GH) Coverage Initiated at Bank of America

Bank of America started coverage on shares of Guardant Health (NASDAQ:GH) in a report issued on Monday morning, Marketbeat.com reports. The firm issued a neutral rating and a $37.00 price objective on the stock.

NASDAQ:GH opened at $33.48 on Monday. Guardant Health has a 52 week low of $27.04 and a 52 week high of $44.25.

About Guardant Health

Guardant Health, Inc is a precision oncology company, which engages in provision of precision oncology testing and development services. It focuses performing blood tests, vast data sets, and advanced analytics to conquer cancer. The company was founded by Helmy Eltoukhy and AmirAli H. Talasaz in 2012 and is headquartered in Redwood City, CA.

Featured Article: Using the New Google Finance Tool

Analyst Recommendations for Guardant Health (NASDAQ:GH)

Receive News & Ratings for Guardant Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Guardant Health and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply